Claris Lifesciences informs about company updates

01 Jun 2017 Evaluate

Claris Lifesciences (CLL) along with its wholly owned subsidiary Claris Injectables Limited (CIL) has informed that it underwent a successful USFDA Pharmacovigilance (PV) audit from Monday 29th May to Wednesday 31st May with No Observation (i483s).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Redington 268.45
Adani Enterprises 2215.10
Amrapali Industries 14.29
Rashi Peripheral 354.00
PDS 371.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×